PEGylated Multi-Walled Carbon Nanotubes for Encapsulation and Sustained Release of Oxaliplatin
详细信息 查看全文
- 作者：Linlin Wu (1)
Changjun Man (2)
Hong Wang (3)
Xiaohe Lu (4)
Qinghai Ma (1)
Yu Cai (5)
Wanshan Ma (1) - 关键词：carbon nanotube ; cytotoxicity ; HT29 cell line ; oxaliplatin ; PEGylation
- 刊名：Pharmaceutical Research
- 出版年：2013
- 出版时间：February 2013
- 年：2013
- 卷：30
- 期：2
- 页码：412-423
- 全文大小：725KB
- 参考文献：1. Chiu SJ, Chao JI, Lee YJ, Hsu TS. Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells. Toxicol Lett. 2008;179(2):63鈥?0. Epub 2008/05/24. CrossRef
2. Simpson D, Dunn C, Curran M, Goa KL. Oxaliplatin: a review of its use in combination therapy for advanced metastatic colorectal cancer. Drugs. 2003;63(19):2127鈥?6. Epub 2003/09/10. CrossRef
3. Alcindor T, Beauger N. Oxaliplatin: a review in the era of molecularly targeted therapy. Curr Oncol. 2011;18(1):18鈥?5. Epub 2011/02/19. CrossRef
4. Mani S, Graham MA, Bregman DB, Ivy P, Chaney SG. Oxaliplatin: a review of evolving concepts. Cancer Invest. 2002;20(2):246鈥?3. Epub 2002/03/21. CrossRef
5. James E, Podoltsev N, Salehi E, Curtis BR, Saif MW. Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect? Clin Colorectal Cancer. 2009;8(4):220鈥?. Epub 2009/10/14. CrossRef
6. Samol J, Waterston A. Oxaliplatin-induced coronary artery spasm: first report of an important side-effect. BMJ Case Rep. 2009;2009. Epub 2009/01/01.
7. Pasetto LM, D鈥橝ndrea MR, Rossi E, Monfardini S. Oxaliplatin-related neurotoxicity: how and why? Crit Rev Oncol Hematol. 2006;59(2):159鈥?8. Epub 2006/06/30. CrossRef
8. Xu YY, Du YZ, Yuan H, Liu LN, Niu YP, Hu FQ. Improved cytotoxicity and multidrug resistance reversal of chitosan based polymeric micelles encapsulating oxaliplatin. J Drug Target. 2011;19(5):344鈥?3. Epub 2010/09/22. CrossRef
9. Franzen U, Nguyen TTTN, Vermehren C, Gammelgaard B, Ostergaard J. Characterization of a liposome-based formulation of oxaliplatin using capillary electrophoresis: encapsulation and leakage. J Pharm Biomed Anal. 2011;55(1):16鈥?2. CrossRef
10. Suzuki R, Takizawa T, Kuwata Y, Mutoh M, Ishiguro N, Utoguchi N, / et al. Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome. Int J Pharm. 2008;346(1鈥?):143鈥?0. CrossRef
11. Li JQ, Wang SL, Xu F, Liu ZY, Li R. Therapeutic effectiveness of slow-release PLGA-oxaliplatin microsphere on human colorectal tumor-bearing mice. Anticancer Drugs. 2010;21(6):600鈥?. Epub 2010/06/10. CrossRef
12. Iijima S. Helical microtubules of graphitic carbon. Nature. 1991;354(6348):56鈥?. CrossRef
13. Bhirde AA, Patel V, Gavard J, Zhang G, Sousa AA, Masedunskas A, / et al. Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano. 2009;3(2):307鈥?6. Epub 2009/02/25. CrossRef
14. Serag MF, Kaji N, Gaillard C, Okamoto Y, Terasaka K, Jabasini M, / et al. Trafficking and subcellular localization of multiwalled carbon nanotubes in plant cells. ACS Nano. 2011;5(1):493鈥?. Epub 2010/12/15. CrossRef
15. Hilder TA, Hill JM. Carbon nanotubes as drug delivery nanocapsules. Curr Appl Phys. 2008;8(3鈥?):258鈥?1. CrossRef
16. Tasis D, Tagmatarchis N, Bianco A, Prato M. Chemistry of carbon nanotubes. Chem Rev. 2006;106(3):1105鈥?6. CrossRef
17. Zhao B, Hu H, Yu A, Perea D, Haddon RC. Synthesis and characterization of water soluble single-walled carbon nanotube graft copolymers. J Am Chem Soc. 2005;127(22):8197鈥?03. Epub 2005/06/02. CrossRef
18. Ajima K, Yudasaka M, Murakami T, Maigne A, Shiba K, Ijima S. Carbon nanohorns as anticancer drug carriers. Mol Pharm. 2005;2(6):475鈥?0. CrossRef
19. Feazell RP, Nakayama-Ratchford N, Dai H, Lippard SJ. Soluble single-walled carbon nanotubes as longboat delivery systems for Platinum(IV) anticancer drug design. J Am Chem Soc. 2007;129(27):8438鈥?. CrossRef
20. Ren HX, Chen X, Liu JH, Gu N, Huang XJ. Toxicity of single-walled carbon nanotube: how we were wrong? Mater Today. 2010;13(1鈥?):6鈥?. CrossRef
21. Nayak TR, Leow PC, Ee PLR, Arockiadoss T, Ramaprabhu S, Pastorin G. Crucial parameters responsible for carbon nanotubes toxicity. Curr Nanosci. 2010;6(2):141鈥?4. CrossRef
22. Xu JM, Song ST, Tang ZM, Liu XQ, Jiang ZF, Zhou L, / et al. Evaluation of in vitro chemosensitivity of antitumor drugs using the MTT assay in fresh human breast cancer. Breast Cancer Res Treat. 1998;49(3):251鈥?. Epub 1998/10/17. CrossRef
23. Xu JM, Azzariti A, Colucci G, Paradiso A. The effect of gefitinib (Iressa, ZD1839) in combination with oxaliplatin is schedule-dependent in colon cancer cell lines. Cancer Chemother Pharmacol. 2003;52(6):442鈥?. Epub 2003/09/19. CrossRef
24. Walker DL, Reid JM, Svingen PA, Rios R, Covey JM, Alley MC, / et al. Murine pharmacokinetics of 6-aminonicotinamide (NSC 21206), a novel biochemical modulating agent. Biochem Pharmacol. 1999;58(6):1057鈥?6. Epub 1999/10/06. CrossRef
25. Balin-Gauthier D, Delord JP, Pillaire MJ, Rochaix P, Hoffman JS, Bugat R, / et al. Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation. Br J Cancer. 2008;98(1):120鈥?. Epub 2008/01/10. CrossRef
26. Yudasaka M, Ajima K, Suenaga K, Ichihashi T, Hashimoto A, Iijima S. Nano-extraction and nano-condensation for C-60 incorporation into single-wall carbon nanotubes in liquid phases. Chem Phys Lett. 2003;380(1鈥?):42鈥?. CrossRef
27. Li J, Yap SQ, Yoong SL, Nayak TR, Chandra GW, Ang WH, / et al. Carbon nanotube bottles for incorporation, release and enhanced cytotoxic effect of cisplatin. Carbon. 2012;50(4):1625鈥?4. CrossRef
28. Ajima K, Yudasaka M, Maigne A, Miyawaki J, Iijima S. Effect of functional groups at hole edges on cisplatin release from inside single-wall carbon nanohorns. J Phys Chem B. 2006;110(11):5773鈥?. CrossRef
29. Worle-Knirsch JM, Pulskamp K, Krug HF. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 2006;6(6):1261鈥?. Epub 2006/06/15. CrossRef
30. Zhang Y, Xu Y, Li Z, Chen T, Lantz SM, Howard PC, / et al. Mechanistic toxicity evaluation of uncoated and PEGylated single-walled carbon nanotubes in neuronal PC12 cells. ACS Nano. 2011;5(9):7020鈥?3. Epub 2011/08/27. CrossRef
31. Coccini T, Roda E, Sarigiannis DA, Mustarelli P, Quartarone E, Profumo A, / et al. Effects of water-soluble functionalized multi-walled carbon nanotubes examined by different cytotoxicity methods in human astrocyte D384 and lung A549 cells. Toxicology. 2010;269(1):41鈥?3. Epub 2010/01/19. CrossRef
32. Han YG, Xu J, Li ZG, Ren GG, Yang Z. In vitro toxicity of multi-walled carbon nanotubes in C6 rat glioma cells. Neurotoxicology. 2012. Epub 2012/06/26.
33. Chaney SG, Campbell SL, Bassett E, Wu Y. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts. Crit Rev Oncol Hematol. 2005;53(1):3鈥?1. Epub 2004/12/21. CrossRef
34. Jamieson ER, Lippard SJ. Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev. 1999;99(9):2467鈥?8. Epub 2001/12/26. CrossRef
35. Johnson SW, Perez RP, Godwin AK, Yeung AT, Handel LM, Ozols RF, / et al. Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines. Biochem Pharmacol. 1994;47(4):689鈥?7. Epub 1994/02/11. CrossRef
36. Cadet J, Bellon S, Douki T, Frelon S, Gasparutto D, Muller E, / et al. Radiation-induced DNA damage: formation, measurement, and biochemical features. J Environ Pathol Toxicol Oncol: official organ of the International Society for Environmental Toxicology and Cancer. 2004;23(1):33鈥?3. Epub 2004/03/05. CrossRef
37. Asaithamby A, Chen DJ. Cellular responses to DNA double-strand breaks after low-dose gamma-irradiation. Nucleic Acids Res. 2009;37(12):3912鈥?3. Epub 2009/04/30. CrossRef
38. Taneja N, Davis M, Choy JS, Beckett MA, Singh R, Kron SJ, / et al. Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem. 2004;279(3):2273鈥?0. Epub 2003/10/17. CrossRef
39. Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A, / et al. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat Cell Biol. 2003;5(7):675鈥?. Epub 2003/06/07. CrossRef
40. Furuta T, Takemura H, Liao ZY, Aune GJ, Redon C, Sedelnikova OA, / et al. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J Biol Chem. 2003;278(22):20303鈥?2. Epub 2003/03/28. CrossRef - 作者单位：Linlin Wu (1)
Changjun Man (2)
Hong Wang (3)
Xiaohe Lu (4)
Qinghai Ma (1)
Yu Cai (5)
Wanshan Ma (1)
1. Department of Laboratory Medicine, Shandong Provincial Qianfoshan Hospital & Shandong University, 16766 Jingshi Road, Jinan, People鈥檚 Republic of China, 250014
2. Department of Clinical Laboratory, Jining Hospital of Infectious Diseases, Jiumiguzui Northern Suburb of Jining, Jining, People鈥檚 Republic of China, 272031
3. Shandong Provincial Qianfoshan Hospital, 16766 Jingshi Rd., Jinan, People鈥檚 Republic of China, 250014
4. Shandong Academy of Medical Sciences, Shandong Provincial Qianfoshan Hospital, 16766 Jingshi Rd., Jinan, People鈥檚 Republic of China, 250014
5. School of Pharmacy, Jinan University, 601 W Huangpu Rd., Guangzhou, People鈥檚 Republic of China, 510632 - ISSN：1573-904X
文摘